Perceived symptoms amongst hypertensive patients in routine clinical practice - A population-based study

Journal of Internal Medicine

Volumn 244, Issue 4, 1998, Pages 325-332

  Kjellgren, K I ^a   Ahlner, J ^a   Dahlof B ^b   Gill, H ^a   Hedner, T ^b   Saljo R ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Clinical practice; Drug therapy; Hypertension

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE;

ADULT; ADVERSE DRUG REACTION; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZATION; SYMPTOM; VERTIGO;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; SWEDEN;

EID: 0031669388     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00377.x     Document Type: Article

References (26)

1. Jern S, Zanchetti A. The issue of quality of life in antihypertensive therapy. J Hum Hypertens 1993; 7 (Suppl. 1):S46-S49.
2. Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 314: 1657-64.
3. Curb JD, Borhani NO, Blaszkowski TP, Zimbaldi N, Fotiu S, Williams W. Long-term surveillance for adverse effects of antihypertensive drugs. JAMA 1985; 253: 3263-8.
4. Nelson EC, Stason WB, Neutra RR, Solomon HS, McArdle PJ. Impact of patient perceptions on compliance with treatment for hypertension. Med Care 1978; XVI: 893-906.
5. Battersby C, Hartley K, Fletcher AE, Markowe HJL, Styles W, Sapper H, Bulpitt CJ. Quality of life in treated hypertension: a case-control community based study. J Hum Hypertens 1995; 9: 981-6.
6. White KL, Williams TF, Greenberg BG. The ecology of medical care. N Engl J Med 1961; 265: 885-92.
7. Kullman S, Svärdsudd K. Differences in perceived symptoms/quality of life in untreated hypertensive and normotensive men. Scand J Prim Health Care 1990; 8 (Suppl. 1): 47-53.
8. Reidenberg MM, Lowenthal DT. Adverse nondrug reactions. N Engl J Med 1968; 279: 678-9.
9. Hasford J. Compliance and the benefit/risk relationship of antihypertensive treatment. J Cardiovasc Pharmacol 1992; 20 (Suppl. 6): S30-S34.
10. Mancia G, Lanfranchi A, Cattaneo BM, Grassi G. When patients are rendered normotensive. Cardiology 1994; 85 (Suppl. 1): 58-64.
11. Müller A, Montoya P, Schandry R, Hartl L. Changes in physical symptoms, blood pressure and quality of life over 30 days. Behav Res 1994; 32: 593-603.
12. Bengtsson C, Edström K, Furunes B, Sigurdsson JA, Tibblin G. Prevalence of subjectively experienced symptoms in a population sample of women with special reference to women with arterial hypertension. Scand J Prim Health Care 1987; 5: 155-62.
13. Schoenberger JA, Croog SH, Sudilovky A, Levine S, Baume RM. Self-reported side effects from antihypertensive drugs. A clinical trial. Am J Hypertens 1990; 5: 123-32.
14. Siegrist J, Matschinger H, Motz W. Untreated hypertensives and their quality of life. J Hypertens 1987; 5 (Suppl. 1): S15-S20.
15. The Swedish Council on Technology Assessment in Health Care. Moderately elevated blood pressure. J Intern Med 1995; 238 (Suppl. 737): 117-27.
16. Jones JK, Gorkin L, Lian JF, Staffa JA, Fletcher AP. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. Br Med J 1995; 311: 293-5.
17. Kirkwood BR. Essentials of Medical Statistics. Oxford: Blackwell Scientific Publications, 1994; 194-7.
18. Nilsson P, Andersson DKG, Andersson P-K, Schwan Å, Östlind B, Malmborg R et al. Cardiovascular risk factors in treated hypertensives - a nation-wide, cross-sectional study in Sweden. J Intern Med 1993; 233: 239-45.
19. Os I, Bratland B, Dahlöf B, Gisholl K, Syvertsen J-O, Tretli S. Lisinopril or nifedipine in essential hypertension? A Norwegian multicenter study on efficacy, tolerability and quality of life in 828 patients. J Hypertens 1991; 9: 1097-104.
20. Dahlöf B, Lindholm LH, Carney S, Pentikäinen PJ, Östergren J. Main results of the losartan vs. amlodipine (LOA) study on drug tolerability and psychological general well-being. J Hypertens 1997; 15: 1327-35.
21. Huskisson EC. Visual analogue scales. In: Melzack R, ed. Pain Measurement and Assessment. New York: Raven Press, 1983; 53-7.
22. Kjellgren KI, Ahlner J, Svensson S, Säljö R. Hypertensive patients' knowledge of high blood pressure. Scand J Prim Health Care 1997; 15: 188-92.
23. Jackson R, Barham P, Bills J, Birch T, McLennan L, MacMahon S, Maling T. Management of raised blood pressure in New Zealand: a discussion document. Br Med J 1993; 307: 107-10.
24. Kannel WB. Potency of vascular risk factors as the basis for antihypertensive therapy. Eur Heart J 1992; 13 (Suppl. G): 34-42.
25. Hansson L, Zanchetti A. for the HOT study group. The Hypertension Optimal Treatment (HOT) study: 24-month data on blood pressure and tolerability. Blood Press 1997; 6: 313-7.
26. Levy D, Anderson KM, Savage DD, Balkus SA, Kannel WB, Castelli WP. Risk of ventricular arrhythmias in left ventricular hypertrophy: The Framingham heart study. Am J Cardiol 1987; 60: 560-5.